Indication
Cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic Human Papillomavirus (HPV) types. 1
The use of Cervarix should be in accordance with official recommendations.
Cervarix is a registered trademark of GlaxoSmithKline group of companies.